In a filing, Moleculin Biotech Inc revealed its Chief Financial Officer Foster Jonathan P. acquired Company’s shares for reported $100000.0 on Jun 23 ’25. In the deal valued at $0.37 per share,270,270 shares were bought. As a result of this transaction, Foster Jonathan P. now holds 287,587 shares worth roughly $89151.97.
Then, KLEMP WALTER V bought 675,675 shares, generating $250,000 in total proceeds. Upon buying the shares at $0.37, the CEO and President now owns 743,607 shares.
A number of analysts have revised their coverage, including Maxim Group’s analysts, who decreased its forecast for the stock in mid February from “a Buy” to “a Hold”.
Price Performance Review of MBRX
On Friday, Moleculin Biotech Inc [NASDAQ:MBRX] saw its stock fall -3.04% to $0.31. Over the last five days, the stock has gained 16.93%. Moleculin Biotech Inc shares have fallen nearly -91.12% since the year began. Nevertheless, the stocks have fallen -81.64% over the past one year. While a 52-week high of $4.71 was reached on 02/13/25, a 52-week low of $0.25 was recorded on 06/20/25.
Levels Of Support And Resistance For MBRX Stock
The 24-hour chart illustrates a support level at 0.2968, which if violated will result in even more drops to 0.2814. On the upside, there is a resistance level at 0.3258. A further resistance level may holdings at 0.3394.
How much short interest is there in Moleculin Biotech Inc?
A steep rise in short interest was recorded in Moleculin Biotech Inc stocks on 2025-06-13, growing by 0.95 million shares to a total of 1.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 0.98 million shares. There was a rise of 49.22%, which implies that there is a positive sentiment for the stock.
